Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary Bypass
Public ClinicalTrials.gov record NCT02771509. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Prospective, Parallel-Group, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Study of ANG-3777 to Assess the Safety and Efficacy of BB3 in Patients Developing Acute Kidney Injury After Cardiac Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of the study is to assess the safety and efficacy of ANG-3777 in preventing AKI compared to placebo when administered to patients at risk for developing acute kidney injury (AKI) following cardiac surgical procedures involving cardiopulmonary bypass (CPB).
Study identification
- NCT ID
- NCT02771509
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 275 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 24, 2017 (Actual)
- Primary completion
- Aug 2021 (Estimated)
- Completion
- Aug 2021 (Estimated)
- Last update posted
- Jul 15, 2021
2017 – 2021
United States locations
- U.S. sites
- 23
- U.S. states
- 12
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90033 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Stanford University Medical Center | Palo Alto | California | 94304 | — |
| California Institute of Renal Reseach | San Diego | California | 92123 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06520 | — |
| Fleming Island Center for Clinical Research | Fleming Island | Florida | 32207 | — |
| UF Health at Unviersity of Florida | Gainesville | Florida | 32610 | — |
| River City Clinical Research | Jacksonville | Florida | 32207 | — |
| Indiana Ohio Heart | Fort Wayne | Indiana | 46804 | — |
| University of Maryland Medical Center | Baltimore | Maryland | 21201 | — |
| Suburban Hospital | Bethesda | Maryland | 20814 | — |
| MidMichigan Medical Center Midland | Midland | Michigan | 49770 | — |
| Cardiac & Vascular Research Center of Northern Michigan | Petoskey | Michigan | 49770 | — |
| Bryan Heart | Lincoln | Nebraska | 68506 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| TriHealth | Cincinnati | Ohio | 45220 | — |
| Cleveland Clinic Fairview | Cleveland | Ohio | 44111 | — |
| Ohio State Wexner Medical Center | Columbus | Ohio | 43210 | — |
| Baylor Jack and Jane Hamilton Heart and Vascular center- Soltero Cardiovascular Research Center | Dallas | Texas | 75226 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22903 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02771509, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 15, 2021 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02771509 live on ClinicalTrials.gov.